This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Dec;17(12):1221-1222.

doi: 10.1016/S1473-3099(17)30537-6. Epub 2017 Sep 22.

Finding the right combination antiviral therapy for influenza

Michael G Ison¹

Affiliations

Affiliation

¹ Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address: mgison@northwestern.edu.

PMID: 28958679
DOI: 10.1016/S1473-3099(17)30537-6

Comment

Finding the right combination antiviral therapy for influenza

Michael G Ison. Lancet Infect Dis. 2017 Dec.

. 2017 Dec;17(12):1221-1222.

doi: 10.1016/S1473-3099(17)30537-6. Epub 2017 Sep 22.

Author

Michael G Ison¹

Affiliation

¹ Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address: mgison@northwestern.edu.

PMID: 28958679
DOI: 10.1016/S1473-3099(17)30537-6

No abstract available

PubMed Disclaimer

Comment on

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.
Beigel JH, Bao Y, Beeler J, Manosuthi W, Slandzicki A, Dar SM, Panuto J, Beasley RL, Perez-Patrigeon S, Suwanpimolkul G, Losso MH, McClure N, Bozzolo DR, Myers C, Holley HP Jr, Hoopes J, Lane HC, Hughes MD, Davey RT; IRC003 Study Team. Beigel JH, et al. Lancet Infect Dis. 2017 Dec;17(12):1255-1265. doi: 10.1016/S1473-3099(17)30476-0. Epub 2017 Sep 22. Lancet Infect Dis. 2017. PMID: 28958678 Free PMC article. Clinical Trial.

Similar articles

Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro.
Haasbach E, Hartmayer C, Planz O. Haasbach E, et al. Antiviral Res. 2013 May;98(2):319-24. doi: 10.1016/j.antiviral.2013.03.006. Epub 2013 Mar 20. Antiviral Res. 2013. PMID: 23523553
Antiviral drugs in influenza: an adjunct to vaccination in some situations.
[No authors listed] [No authors listed] Prescrire Int. 2006 Feb;15(81):21-30. Prescrire Int. 2006. PMID: 16548114
The use of antiviral agents for the management of severe influenza.
Smith JR, Ariano RE, Toovey S. Smith JR, et al. Crit Care Med. 2010 Apr;38(4 Suppl):e43-51. doi: 10.1097/CCM.0b013e3181c85229. Crit Care Med. 2010. PMID: 19935416 Review.
Probenecid with oseltamivir for human influenza A (H5N1) virus infection?
Howton JC. Howton JC. N Engl J Med. 2006 Feb 23;354(8):879-80. doi: 10.1056/NEJMc052951. N Engl J Med. 2006. PMID: 16495407 No abstract available.
Oseltamivir for influenza infection in children: risks and benefits.
Esposito S, Principi N. Esposito S, et al. Expert Rev Respir Med. 2016;10(1):79-87. doi: 10.1586/17476348.2016.1126182. Epub 2015 Dec 19. Expert Rev Respir Med. 2016. PMID: 26616633 Review.

See all similar articles

Cited by

An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil.
Gaisina I, Li P, Du R, Cui Q, Dong M, Zhang C, Manicassamy B, Caffrey M, Moore T, Cooper L, Rong L. Gaisina I, et al. Sci Adv. 2024 Feb 23;10(8):eadk9004. doi: 10.1126/sciadv.adk9004. Epub 2024 Feb 23. Sci Adv. 2024. PMID: 38394202 Free PMC article.
Advances in Development and Application of Influenza Vaccines.
Chen J, Wang J, Zhang J, Ly H. Chen J, et al. Front Immunol. 2021 Jul 13;12:711997. doi: 10.3389/fimmu.2021.711997. eCollection 2021. Front Immunol. 2021. PMID: 34326849 Free PMC article. Review.
Chloroquine, an Anti-Malaria Drug as Effective Prevention for Hantavirus Infections.
Vergote V, Laenen L, Mols R, Augustijns P, Van Ranst M, Maes P. Vergote V, et al. Front Cell Infect Microbiol. 2021 Mar 15;11:580532. doi: 10.3389/fcimb.2021.580532. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33791230 Free PMC article.
Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection.
Fukao K, Noshi T, Yamamoto A, Kitano M, Ando Y, Noda T, Baba K, Matsumoto K, Higuchi N, Ikeda M, Shishido T, Naito A. Fukao K, et al. J Antimicrob Chemother. 2019 Mar 1;74(3):654-662. doi: 10.1093/jac/dky462. J Antimicrob Chemother. 2019. PMID: 30476172 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information